Brain structure study for people with schizophrenia
Part of Mental health clinical trials.
This study uses a special MRI technique to measure brain structure differences in people with schizophrenia, including those who also have nicotine dependence. Your participation could help researchers understand more about the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with schizophrenia (for the main study group).
- You are between 18 and 60 years old.
- Your schizophrenia medication has been stable for at least 2 months.
- You are able to give consent, or a caregiver can give it for you.
- You do not have any other major brain or mental health conditions (other than schizophrenia or nicotine use).
- You do not have metal implants (like a pacemaker), severe claustrophobia, or other reasons that prevent an MRI scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain scans to look at how a specific brain area works in schizophrenia. If you qualify, it may help researchers better understand the brain changes linked to symptoms.
This study uses a special brain scan (functional MRI) to look at how schizophrenia affects thinking and memory. It may help researchers understand why some people with schizophrenia have trouble with concentration, planning, or remembering things.
This early (Phase 1) study uses a special brain scan to look at synapses—the contact points between brain cells—in people with schizophrenia-related conditions. It helps researchers understand brain activity and connection patterns, which may guide future tests or treatments.
This study uses brain scans and real-life surveys to understand how people with or without schizophrenia make decisions. It may help researchers learn how the brain works differently in schizophrenia.
This study tests a circuitry-guided approach to help people with schizophrenia quit smoking. It may help reduce cravings and improve quitting, while also watching for safety issues.
This study uses brain scans (PET and MRI) to see how a specific receptor, called D3, is affected by antipsychotic medications in people with schizophrenia. You may be able to participate if you have not taken antipsychotics for at least 3 weeks and are not using nicotine products.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.